Guangfeng Shi

Department of Infectious Diseases, Fudan University

Research Area

Biography

Guangfeng Shi has not added Biography.
If you are Guangfeng Shi and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 2	2022

Other Publications

Article	Year
Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo. World journal of gastroenterology\| PubMed ID: 15633229	2005
Impaired TLR3/IFN-beta signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: relevance to the severity of liver damage. Biochemical and biophysical research communications\| PubMed ID: 19833099	2009
A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol. Hepatology international\| PubMed ID: 21773778	2012
Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PloS one\| PubMed ID: 22039417	2011
[Rational use of antibiotics in patients with hepatic dysfunction]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology\| PubMed ID: 22629581	2012
Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells. Journal of ethnopharmacology\| PubMed ID: 23127651	2013
Cyclooxygenase-2 promotes hepatocellular apoptosis by interacting with TNF-α and IL-6 in the pathogenesis of nonalcoholic steatohepatitis in rats. Digestive diseases and sciences\| PubMed ID: 23975340	2013
[A meta-analysis of diammonium glycyrrhizinate enteric-coated capsules versus diammonium glycyrrihizinate in patients with chronic viral hepatitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology\| PubMed ID: 25203702	2014
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues. Gut\| PubMed ID: 25586058	2016
The function of MicroRNA in hepatitis B virus-related liver diseases: from Dim to Bright. Annals of hepatology\| PubMed ID: 26019030	2015
Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study. Journal of hepatology\| PubMed ID: 27238752	2016
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis. Medicine\| PubMed ID: 27893675	2016
Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage. Clinics and research in hepatology and gastroenterology\| PubMed ID: 28041935	2017
Interleukin-23 mediates the pathogenesis of LPS/GalN-induced liver injury in mice. International immunopharmacology\| PubMed ID: 28282579	2017
MicroRNA-548j inhibits type I interferon production by targeting ZBTB11 in patients with chronic hepatitis B. Biochemical and biophysical research communications\| PubMed ID: 28342861	2017
The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review). Molecular medicine reports\| PubMed ID: 28731149	2017
Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis. Gut and liver\| PubMed ID: 28750488	2017
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B. Hepatology research : the official journal of the Japan Society of Hepatology\| PubMed ID: 28834607	2018
miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7. Journal of molecular medicine (Berlin, Germany)\| PubMed ID: 29051972	2018
Involvement of epithelial-mesenchymal transition in liver fibrosis. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association\| PubMed ID: 29451178	2018
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir. Journal of viral hepatitis\| PubMed ID: 30624000	2019
Comparison of non-invasive models for predicting liver damage in chronic hepatitis B patients. Gastroenterologia y hepatologia\| PubMed ID: 30772087	2019
Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 31362119	2019
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway. PeerJ\| PubMed ID: 34040893	2021
Methyl Butyrate Alleviates Experimental Autoimmune Encephalomyelitis and Regulates the Balance of Effector T Cells and Regulatory T Cells. Inflammation\| PubMed ID: 34786625	2022
Methyl butyrate attenuates concanavalin A-induced autoimmune hepatitis by inhibiting Th1-cell activation and homing to the liver. Cellular immunology\| PubMed ID: 35779312	2022